Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  EGFR inhibitor ABT-414
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: M14-483, NCI-2015-01199, 2014-004438-24, EORTC 1410-BTG, NCI-2015-01200, NCT02343406
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: M12-356, NCI-2013-01759, 2012-003884-23, NCT01800695
A Study of ABT-414 in Subjects With Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: M13-379, NCI-2014-00516, NCT01741727
Start Over